SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : RMGG

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DR. MEADE who started this subject11/16/2000 3:16:03 PM
From: jmhollen  Read Replies (2) of 1170
 
ROCKY MOUNTAIN (FUZHOU) DRUG CO., LTD.

SIGNS NON-DISCLOSURE AGREEMENT


VANCOUVER, British Columbia--(BUSINESS WIRE)--Nov. 15, 2000--The Board of Directors of Rocky Mountain Ginseng, Inc. (Pink Sheets: RMGG) wish to provide a status report concerning the Company's efforts to raise capital for its China operations.

Rocky Mountain (Fuzhou) Drug Co., Ltd. ("RM Fuzhou") has signed a non-disclosure agreement with a large national drug store chain located in Shenzhen. RM Fuzhou is considering acquiring a portion of this company which manufactures and sells its own line of pharmaceutical
products.

Presently this Shenzhen company is a federally owned company which plans to go public.

With China joining the WTO, it is imperative that federally owned companies have private investors. RM Fuzhou believes that many international drug companies are heading to China to invest in drug factories to take advantage of the ongoing demand for Western drugs, and RM Fuzhou believes that is poised to take advantage of this opportunity. The opportunity may also attract outside investors to Rocky Mountain Ginseng, Inc., thereby increasing the chance of
raising much needed capital for the China operation.

ABOUT ROCKY MOUNTAIN GINSENG, INC.

Rocky Mountain Ginseng, Inc.'s head office is located in British Columbia, Canada. The Company exports American ginseng to China as well as manufactures and processes America ginseng products in China.

Rocky Mountain Ginseng, Inc. holds exclusive world processing and distribution rights to several innovative value added ginseng products developed in North America.

Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company located in China in February 1999. This acquisition included all necessary drug and hygiene licenses allowing the Company to import, export, manufacture and distribute ginseng products in all provinces of China.

The Company has completed the construction of its new office and manufacturing facility in the city of Fuzhou and is currently producing traditional ginseng products for the Chinese Market. The Chinese factory employs 42 people in processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is the first wholly owned Canadian Company in the Fujian province.

CONTACT INFORMATION

Rocky Mountain (Fuzhou) Drug Co. Ltd.
Brian A. Hodge, President
(86) 591-379-7969 (phone)
e-mail: rockymt@public.fz.fj.cn
Website: www.RMGGInvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext